SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:134926503"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:134926503" > Dalotuzumab in chem...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial

Sclafani, F (author)
Kim, TY (author)
Cunningham, D (author)
show more...
Kim, TW (author)
Tabernero, J (author)
Schmoll, HJ (author)
Roh, JK (author)
Kim, SY (author)
Park, YS (author)
Guren, TK (author)
Hawkes, E (author)
Clarke, SJ (author)
Ferry, D (author)
Frodin, JE (author)
Karolinska Institutet
Ayers, M (author)
Nebozhyn, M (author)
Peckitt, C (author)
Loboda, A (author)
Watkins, DJ (author)
show less...
 (creator_code:org_t)
2016-10-17
2017
English.
In: International journal of cancer. - : Wiley. - 1097-0215 .- 0020-7136. ; 140:2, s. 431-439
  • Journal article (peer-reviewed)
Subject headings
Close  

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view